BACKGROUND AND OBJECTIVES: Antiglomerular basement membrane autoantibodies are pathogenic in antiglomerular basement membrane disease with two major epitopes, E(A) and E(B), on α3 chain of type IV collagen. This study investigated the epitope spectrum of antiglomerular basement membrane autoantibodies, aiming to identify the association between epitope specificity and kidney injury. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All 108 patients with antiglomerular basement membrane disease and complete clinical data were divided into three groups according to renal dysfunction: mild group (n=20) with serum creatitine≤1.5 mg/dl; moderate group (n=22) with serum creatinine=1.5-6.8 mg/dl; severe group (n=66) with serum creatitine≥6.8 mg/dl. Epitope spectrums of antibodies were determined by ELISA, and their associations with kidney damage were analyzed. Sequential serum samples in 40 patients were examined during disease courses. RESULTS: E(A) and E(B) were recognized in 79.6% and 72.2% of patients, respectively. E(A) and E(B) reactions were the lowest in the mild group and higher in the moderate group (E(A): 35.0% versus 81.8%, P=0.002; E(B): 15.0% versus 68.2%, P=0.001). They were the highest in the severe group (E(A): 92.4%, P=0.31; E(B): 90.9%, P=0.02). Close association was observed between renal injury and E(A) and E(B) reactions. Multivariate Cox regression analysis showed that E(B) reaction was an independent risk factor for renal failure (hazard ratio=6.91, P=0.02). The recognition for non-E(AB) remained low among groups. No augmentation of epitope spectrum was shown in serial serum samples. CONCLUSIONS: Intramolecular epitope spreading might occur before the onset of human antiglomerular basement membrane disease. The autoimmunity to E(A) and E(B), especially E(B), was crucial for kidney dysfunction.
BACKGROUND AND OBJECTIVES: Antiglomerular basement membrane autoantibodies are pathogenic in antiglomerular basement membrane disease with two major epitopes, E(A) and E(B), on α3 chain of type IV collagen. This study investigated the epitope spectrum of antiglomerular basement membrane autoantibodies, aiming to identify the association between epitope specificity and kidney injury. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All 108 patients with antiglomerular basement membrane disease and complete clinical data were divided into three groups according to renal dysfunction: mild group (n=20) with serum creatitine≤1.5 mg/dl; moderate group (n=22) with serum creatinine=1.5-6.8 mg/dl; severe group (n=66) with serum creatitine≥6.8 mg/dl. Epitope spectrums of antibodies were determined by ELISA, and their associations with kidney damage were analyzed. Sequential serum samples in 40 patients were examined during disease courses. RESULTS: E(A) and E(B) were recognized in 79.6% and 72.2% of patients, respectively. E(A) and E(B) reactions were the lowest in the mild group and higher in the moderate group (E(A): 35.0% versus 81.8%, P=0.002; E(B): 15.0% versus 68.2%, P=0.001). They were the highest in the severe group (E(A): 92.4%, P=0.31; E(B): 90.9%, P=0.02). Close association was observed between renal injury and E(A) and E(B) reactions. Multivariate Cox regression analysis showed that E(B) reaction was an independent risk factor for renal failure (hazard ratio=6.91, P=0.02). The recognition for non-E(AB) remained low among groups. No augmentation of epitope spectrum was shown in serial serum samples. CONCLUSIONS: Intramolecular epitope spreading might occur before the onset of human antiglomerular basement membrane disease. The autoimmunity to E(A) and E(B), especially E(B), was crucial for kidney dysfunction.
Authors: Vadim Pedchenko; Olga Bondar; Agnes B Fogo; Roberto Vanacore; Paul Voziyan; A Richard Kitching; Jörgen Wieslander; Clifford Kashtan; Dorin-Bogdan Borza; Eric G Neilson; Curtis B Wilson; Billy G Hudson Journal: N Engl J Med Date: 2010-07-22 Impact factor: 91.245
Authors: John Reynolds; Evangelia I Prodromidi; Jason K Juggapah; Danielle S Abbott; Kathryn A Holthaus; Raghu Kalluri; Charles D Pusey Journal: J Am Soc Nephrol Date: 2005-04-06 Impact factor: 10.121
Authors: Diane van der Woude; Solbritt Rantapää-Dahlqvist; Andreea Ioan-Facsinay; Carla Onnekink; Carla M Schwarte; Kirsten N Verpoort; Jan W Drijfhout; Tom W J Huizinga; Rene E M Toes; Ger J M Pruijn Journal: Ann Rheum Dis Date: 2010-05-06 Impact factor: 19.103
Authors: Valerie K Salato; Mary K Hacker-Foegen; Zelmira Lazarova; Janet A Fairley; Mong-Shang Lin Journal: Clin Immunol Date: 2005-07 Impact factor: 3.969
Authors: Lanlin Chen; Thomas Hellmark; Vadim Pedchenko; Billy G Hudson; Charles D Pusey; Jay W Fox; W Kline Bolton Journal: J Am Soc Nephrol Date: 2006-09-27 Impact factor: 10.121
Authors: Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas Journal: J Am Soc Nephrol Date: 2018-03-19 Impact factor: 10.121
Authors: Barbara Seitz-Polski; Hanna Debiec; Alexandra Rousseau; Karine Dahan; Christelle Zaghrini; Christine Payré; Vincent L M Esnault; Gérard Lambeau; Pierre Ronco Journal: J Am Soc Nephrol Date: 2017-11-07 Impact factor: 10.121